GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solco Biomedical Co Ltd (XKRX:043100) » Definitions » Gross-Profit-to-Asset %

Solco Biomedical Co (XKRX:043100) Gross-Profit-to-Asset % : 20.14% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Solco Biomedical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Solco Biomedical Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₩10,973 Mil. Solco Biomedical Co's average Total Assets over the quarter that ended in Mar. 2024 was ₩54,483 Mil. Therefore, Solco Biomedical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 20.14%.


Solco Biomedical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Solco Biomedical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solco Biomedical Co Gross-Profit-to-Asset % Chart

Solco Biomedical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.64 17.93 14.37 13.53 9.31

Solco Biomedical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.05 21.70 19.42 -23.07 20.14

Competitive Comparison of Solco Biomedical Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Solco Biomedical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solco Biomedical Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solco Biomedical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Solco Biomedical Co's Gross-Profit-to-Asset % falls into.



Solco Biomedical Co Gross-Profit-to-Asset % Calculation

Solco Biomedical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=4985.996/( (56435.287+50676.951)/ 2 )
=4985.996/53556.119
=9.31 %

Solco Biomedical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=10972.524/( (50676.951+58289.892)/ 2 )
=10972.524/54483.4215
=20.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Solco Biomedical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Solco Biomedical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Solco Biomedical Co (XKRX:043100) Business Description

Traded in Other Exchanges
N/A
Address
34-6 Keumam-ri, Seotan-myeon, Gyeonggi-do, Pyeongtaek, KOR, 451-852
Solco Biomedical Co Ltd operates in the medical devices industry in South Korea. The products offered by the company include dressing and tissue forceps, scissors, needle holders, intestinal forceps, self-retaining retractors, hooks, and knife handles.

Solco Biomedical Co (XKRX:043100) Headlines

No Headlines